TVRD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tvardi Therapeutics Inc (TVRD) is not a strong buy for a beginner, long-term investor at this time. The stock's technical indicators are bearish, options sentiment is neutral, and the company lacks significant financial growth or positive news catalysts. While the analyst upgrade and potential for asset readouts are positive, they are speculative and not immediate. Given the user's impatience and unwillingness to wait for optimal entry points, this stock does not align with their investment profile.
The technical indicators for TVRD are bearish. The MACD is slightly positive but contracting, RSI is neutral at 39.337, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 3.92, with key support at 3.702 and resistance at 4.137.
Lucid Capital upgraded the stock to Buy with a $6 price target, citing undervaluation and potential for asset readouts to drive the stock higher. The stock has an 80% chance of gaining 8.68% in the next month based on historical candlestick patterns.
No significant trading trends from hedge funds or insiders. No recent news or congress trading data. Financial performance is weak, with no revenue growth, negative net income, and a significant drop in EPS (-72.43% YoY).
In Q3 2025, the company reported no revenue growth (0% YoY), a net loss of -$5.53 million (up 0.25% YoY), and a significant decline in EPS (-72.43% YoY). Gross margin remains at 0%.
Lucid Capital upgraded the stock to Buy from Neutral with a $6 price target, citing undervaluation and potential for asset readouts to drive the stock higher. However, this is speculative and dependent on future events.
